The proposed explanation is that ApoA-I is negatively associated with tumor-induced systemic inflammation, while elevated ApoB indicates a higher systemic inflammatory marker, and so a high ApoB/ApoA-I ratio, which is considered atherogenic, may contribute to tumor necrosis. This evidence concerns the gene APOB and neoplasm.